camptothecin has been researched along with Gliosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brem, H; Moriarity, JL; Renard, VM; Storm, PB; Tyler, B; Weingart, JD; Wilentz, RE | 1 |
| Brem, H; Colvin, OM; Thompson, RC; Tyler, B; Weingart, JD | 1 |
| Brem, H; Burger, PC; Moriarity, JL; Storm, PB; Tyler, B; Weingart, J | 1 |
3 other study(ies) available for camptothecin and Gliosarcoma
| Article | Year |
|---|---|
Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma.
Topics: Animals; Brain Neoplasms; Camptothecin; Carmustine; Cell Line, Tumor; Enzyme Inhibitors; Female; Gliosarcoma; Irinotecan; Neoplasm Transplantation; Rats; Rats, Inbred F344; Topoisomerase I Inhibitors | 2004 |
Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model.
Topics: Animals; Brain Neoplasms; Camptothecin; Delayed-Action Preparations; Gliosarcoma; Injections, Intralesional; Male; Polymers; Rats; Rats, Inbred F344; Survival Analysis; Topoisomerase I Inhibitors | 1995 |
Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Drug Implants; Gliosarcoma; Kinetics; Male; Rats; Rats, Inbred F344; Survival Analysis; Time Factors; Tissue Distribution | 2002 |